PRESS RELEASES
CORPORATE FACT SHEET
ARTICLES
SCIENTIFIC PUBLICATIONS

Publications

Posters Presented at 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), October 25-28, 2008

Safety and Efficacy of PTK 0796: Results of the Phase 2 Study in Complicated Skin and Skin Structure Infections Following IV and Oral Step Down Therapy, Poster L-1515b

Efficacy of MAR Inhibitors in a Pseudomonas aeruginosa Pneumonia Model, Poster F1-3958

Poster Presented at 15th International Inflammation Research Association Conference, September 21-24, 2008

Therapeutic Inhibition of Murine Collagen-Induced Arthritis by Non-Antibacterial Derivatives of Minocycline

Poster Presented at 60th Annual Meeting of the American Academy of Neurology, April 12-19, 2008

A Tetracycline That Corrects SMN2 Splicing for Potential Treatment of Spinal Muscular Atrophy (SMA)

Poster Presented at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 18, 2007

A Novel Anti-virulence Approach for Treatment of Pneumonia Caused by Pseudomonas aeruginosa, Poster F2-968a

Poster Presented at 107th General Meeting of the American Society for Microbiology (ASM), May 22, 2007

Small Molecule Inhibitors of Yersinia pseudotuberculosis Transcription Factor LcrF (VirF) Attenuate Virulence and Limit Infection in a Murine Pneumonia Model, Poster A-030

Posters Presented at 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 30, 2006

Antistaphylococcal Activity of MK-2764 / PTK 0796 Compared to Other Agents, Poster F1-1971

In Vitro Activity of MK-2764 / PTK 0796 Against Legionella spp., Poster F1-1972

Pharmacokinetic/Pharmacodynamic Profile of MK-2764 / PTK 0796 against S. pneumoniae in a Murine Pneumonia Model, Poster F1-1973

In Vivo Pharmacodynamics of MK-2764 / PTK 0796 Against Various Gram-positive and Gram-negative Bacteria in the Thighs of Neutropenic and Normal Mice, Poster F1-1974

Posters Presented at 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 15, 2003

In Vitro Activity of BAY 73-6944/PTK 0796 Against Gram-Positive and Gram-Negative Organisms, Poster F-754

Evaluation of BAY 73-6944/PTK 0796 in Experimental Models of Infections Caused by Gram-Positive and Gram-Negative Pathogens, Poster F-757

The Efficacy of BAY 73-6944/PTK 0796 in Murine Models of Streptococcus pneumoniae Infections, Poster F-758

BAY 73-6944/PTK 0796: In Vitro Potency and Spectrum of Activity Compared to Ten Other Antimicrobial Compounds, Poster F-753

BAY 73-6944/PTK 0796: Effects of Environmental Variation on MICs and Confirmation of Disk Mass, Poster F-756

Pharmacokinetics of BAY 73-6944/PTK 0796 in Mouse, Rat and Cynomolgus Monkey, Poster F-759

The Activity of BAY 73-6944/PTK 0796 Against Tetracycline Resistance, Poster F-752

In Vitro Assessment of Plasma Protein Binding and Metabolic Stability of BAY 73-6944/PTK 0796, Poster F-760

The Mechanism of Action of BAY 73-6944/PTK 0796, Poster F-751

BAY 73-6944/PTK 0796 and other Novel Tetracycline Derivatives Exhibiting Potent in vitro and in vivo Activities Against Antibiotic Resistant Gram-Positive Bacteria, Poster F-755